Clinical trial No longer in our active list Early Phase 1 Interventional Ages 10 to 21

Using theta burst stimulation to improve motor function in Tourette Syndrome

Official title: Theta Burst Stimulation to Improve Inhibitory Motor Physiology in Tourette Syndrome

Run by Children's Hospital Medical Center, Cincinnati · NCT05628805 · Data updated 2026-05-14

This study is no longer in our active list. It may have stopped recruiting or finished. The details below are as of 2026-05-14 and are kept for reference. Check ClinicalTrials.gov for its current status, or see similar studies below.

This study is testing whether a new brain stimulation technique can help young people with Tourette Syndrome improve their motor skills.

Quick facts

PhaseEarly Phase 1
Study typeInterventional
Ages10 Years to 21 Years
SexAll
Enrollment30 (estimated)
SponsorChildren's Hospital Medical Center, Cincinnati
Academic / other
Locations1 site (Cincinnati, Ohio)
Trial IDNCT05628805 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates for this study are individuals aged 10-21 years with a DSM-5 diagnosis of Tourette Syndrome who are clinically stable.

Probably not a fit

Patients with additional neurodevelopmental or psychiatric conditions beyond Tourette Syndrome, ADHD, or mild anxiety may not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study aims to explore the effects of intermittent theta-burst stimulation (iTBS) on the motor system in patients with Tourette Syndrome (TS). By utilizing a sham-controlled protocol, the researchers will modulate the output of the pre-supplementary motor area (pre-SMA) to enhance inhibitory control in the motor system. The study focuses on participants aged 10-21 years who have a confirmed diagnosis of TS and are clinically stable. The non-invasive nature of TMS allows for a quick stimulation process, potentially leading to improved motor function in TS patients.

Why it matters

Potential benefit: If successful, this approach could significantly enhance motor inhibition in patients with Tourette Syndrome, improving their quality of life.

How similar studies have gone: While the use of TMS in treating Tourette Syndrome is a relatively novel approach, similar studies have shown promise in modulating brain circuits for other neurological conditions.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

Participants of any sex, race, or ethnicity meeting all criteria listed below will be included in the study:

1. Aged 10-21 years
2. Fluent in English
3. DSM-5 diagnosis of TS, confirmed by the clinical team
4. Able to participate in the informed consent process, provide voluntary informed consent/assent and provide a spontaneous narrative description of the key elements of the study.
5. Clinical stability: determined by a physician, no switch of psychotropic medications or increase in dosage in the last 14 days from TMS treatment start; no change in other therapeutic interventions in last 14 days from TMS treatment start.

Exclusion Criteria:

1. Any neurodevelopmental, psychiatric condition other than TS, ADHD, or OCD, or mild anxiety based on review of K-SADS. Note - if an exclusionary psychiatric diagnosis is suspected based on K-SADS, the research physician will follow up with the parent and referral will be made to psychology or psychiatry as appropriate.
2. Presence of metallic foreign bodies or implanted medical devices.
3. Not meeting inclusion criteria as described above
4. Non-fluency in English, as English is the language in the validated clinical questionnaires, and the participant must be able to understand real-time instructions from the study staff

Where it's running

  • Cincinnati Children's Hospital Medical Center
    Cincinnati, Ohio, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.